Daiwa Securities Group Inc. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 167 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 21.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$03210.0%0.00%
Q2 2022$03210.0%0.00%
Q1 2022$03210.0%0.00%
Q4 2021$0
-100.0%
3210.0%0.00%
Q3 2021$1,0000.0%3210.0%0.00%
Q2 2021$1,0000.0%3210.0%0.00%
Q1 2021$1,0000.0%3210.0%0.00%
Q4 2020$1,000
-66.7%
321
-49.7%
0.00%
Q3 2020$3,000
+200.0%
6380.0%0.00%
Q2 2020$1,0000.0%6380.0%0.00%
Q1 2020$1,000
-50.0%
6380.0%0.00%
Q4 2019$2,000
-66.7%
638
-9.6%
0.00%
Q3 2019$6,0000.0%7060.0%0.00%
Q2 2019$6,000
-25.0%
7060.0%0.00%
Q1 2019$8,000
+60.0%
706
+27.0%
0.00%
Q4 2018$5,000
-44.4%
5560.0%0.00%
Q3 2018$9,000
-25.0%
5560.0%0.00%
Q2 2018$12,000
+33.3%
5560.0%0.00%
Q1 2018$9,000
+800.0%
556
-44.4%
0.00%
Q2 2015$1,000
-99.2%
1,000
-95.2%
0.00%
-100.0%
Q1 2015$133,00021,0000.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,383,466$139,917,00012.64%
ASHFORD CAPITAL MANAGEMENT INC 362,615$6,872,0001.07%
NEXTHERA CAPITAL LP 259,300$4,914,0000.91%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 639,856$12,125,0000.89%
Sonora Investment Management, LLC 249,502$4,728,063,0000.76%
Kazazian Asset Management, LLC 32,526$616,0000.63%
Piermont Capital Management Inc. 88,372$1,675,0000.55%
J. Goldman & Co LP 266,479$5,050,0000.26%
J. Goldman & Co LP 251,500$4,766,0000.25%
Opaleye Management Inc. 31,000$587,0000.19%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders